Skip to content
value.today

Pulsar Vascular Inc.

🇺🇸 Kirkland, Washington, USAHealth CareFounded 2005
Total raised
$11 M
2 rounds on record
Latest round
$9 M
Jul 2015
First round on record
Apr 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pulsar Vascular Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2015$9 MNo. 2$2 to $10 million

Pulsar Vascular Inc.: Raise no. 2, Jul 2015

Investors in this round

39 investors had bought by the notice of Sep 10, 2015: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $10 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$424,200
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Muscarella M Thomas · Executive Officer
  • Robert M Abrams · Executive Officer, Director
  • Matt C. Jenusaitis · Director
  • Timothy C. Mills · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Jennifer L. Halsey · San Jose, CaliforniaSold in CA, FL, MA, NC, NY, WA

Signed by Thomas Muscarella, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 10, 2015. Read the notice at the SEC.

equity, debt, optionsSEC
Apr 2010$1 MNo. 1Under $2 million

Pulsar Vascular Inc.: Raise no. 1, Apr 2010

Investors in this round

4 investors had bought by the notice of Apr 12, 2010: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $1 M still to sell
Smallest investment taken
$21,005
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Gilbert M Clarke · Executive Officer, Director
  • Robert M Abrams · Executive Officer, Director
  • Timothy M Mills · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert M. Abrams, President & CEO. Source: SEC Form D, newest notice filed Apr 12, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pulsar Vascular Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2015).

    SEC Form D · Sep 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2015

That is all the official record says: Pulsar Vascular Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pulsar Vascular Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 39 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pulsar Vascular Inc.
NameRoleNamed in
Muscarella M ThomasExecutive officerSep 2015
Robert M AbramsExecutive officerSep 2015
Gilbert M ClarkeExecutive officerApr 2010
Timothy M MillsExecutive officerApr 2010
Matt C. JenusaitisDirectorSep 2015
Robert M AbramsDirectorSep 2015
Timothy C. MillsDirectorSep 2015
Gilbert M ClarkeDirectorApr 2010
Timothy M MillsDirectorApr 2010